AI Analysis AI Analysis of HALO
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Halozyme Therapeutics stock price ended at $58.61 on Thursday, after gaining 0.86%
(Updated on Feb 13, 2025)

Buy or Hold candidate since Jan 06, 2025 Gain 16.04%

The Halozyme Therapeutics stock price gained 0.86% on the last trading day (Thursday, 13th Feb 2025), rising from $58.11 to $58.61. During the last trading day the stock fluctuated 1.60% from a day low at $57.79 to a day high of $58.72. The price has risen in 7 of the last 10 days and is up by 3.88% over the past 2 weeks. Volume fell on the last day by -13 thousand shares and in total, 848 thousand shares were bought and sold for approximately $49.73 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 23.78% during the next 3 months and, with a 90% probability hold a price between $68.04 and $82.67 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

HALO Signals & Forecast

The Halozyme Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $57.73 and $53.82. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, November 18, 2024, and so far it has risen 37.68%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Halozyme Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $49.00 and $47.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Halozyme Therapeutics finds support just below today's level at $49.00. If this is broken, then the next support from accumulated volume will be at $47.79 and $45.65.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.93 between high and low, or 1.60%. For the last week the stock has had daily average volatility of 1.91%.

Our recommended stop-loss: $56.86 (-2.98%) (This stock has very low daily movements and this gives very low risk. The RSI14 is 76 and this increases the risk substantially. There is a buy signal from a pivot bottom found 58 days ago.)

Trading Expectations (HALO) For The Upcoming Trading Day Of Friday 14th

For the upcoming trading day on Friday, 14th we expect Halozyme Therapeutics to open at $58.37, and during the day (based on 14 day Average True Range), to move between $57.28 and $59.94, which gives a possible trading interval of +/-$1.33 (+/-2.27%) up or down from last closing price. If Halozyme Therapeutics takes out the full calculated possible swing range there will be an estimated 4.53% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $49.00, some $9.61 (16.40%) from the current price of $58.61, our system finds the risk reward attractive.

Earnings coming up

Halozyme Therapeutics will release earnings AMC on Tuesday, February 18, 2025.The consensus among the analysts for the expected earnings (EPS) is $1.17. We will update the financials statements for Halozyme Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 3.60% in the first trading day after earnings release.

Is Halozyme Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Halozyme Therapeutics stock to perform well in the short-term.

Current score: 4.934 Buy Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on February 14, 2025 - $58.37 ( 0.407%).

HALO Performance

Trading levels for HALO

Fibonacci Support & Resistance Levels

Level Price
R3 59.30 1.17%
R2 58.94 0.569%
R1 58.73 0.196%
Price 58.61
S1 58.02 -1.01%
S2 57.80 -1.38%
S3 57.45 -1.98%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 58.61
S1 49.00 -16.40%
S2 47.79 -18.46%
S3 45.65 -22.11%

FAQ

What is the symbol for Halozyme Therapeutics Stock and on which exchange is it traded?
The symbol for Halozyme Therapeutics is HALO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Halozyme Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Halozyme Therapeutics stock to perform well in the short-term.

How to buy Halozyme Therapeutics Stock?
Halozyme Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Halozyme Therapeutics Stock.

What's the current price of Halozyme Therapeutics Stock?
As of the end of day on the Feb 13, 2025, the price of an Halozyme Therapeutics (HALO) share was $58.61.

What is the 52-week high and low for Halozyme Therapeutics Stock?
The 52-week high for Halozyme Therapeutics Stock is $65.53 and the 52-week low is $34.70.

What is the market capitalization of Halozyme Therapeutics Stock?
As of the Feb 13, 2025, the market capitalization of Halozyme Therapeutics is 7.393B.

When is the next earnings date for Halozyme Therapeutics?
The upcoming earnings date for Halozyme Therapeutics is Feb 18, 2025.
Click to get the best stock tips daily for free!
ABOUT HALOZYME THERAPEUTICS
Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a...
GOLDEN STAR
Ticker Change Signal Date
IBN
$29.02
0.448% Feb 11
HCP
$34.11
0.733% Feb 11
VRNT
$26.02
0.92% Feb 11
BSY
$46.63
0.172% Feb 11
LFUS
$234.72
5.50% Feb 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE